Quarterly Results

  • Company Name :
Alivus Life Sciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543322
  • NSE Symbol:
  • ALIVUS
  • P/E(TTM):
  • 23.18
  • ISIN Demat:
  • INE03Q201024
  • Div & Yield%:
  • 0.53
  • EPS(TTM):
  • 40.40
  • Book Value(₹):
  • 229.65
  • Market Cap(₹Cr.):
  • 11,490.95
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 601.85 649.55 641.84
Excise Duty 0.00 0.00 0.00
Net Sales 601.85 649.55 641.84
Other Operating Income 0.00 0.00 0.00
Other Income 8.99 10.09 10.46
Total Income 610.83 659.63 652.30
Total Expenditure 429.54 451.11 451.54
PBIDT 181.30 208.52 200.76
Interest 1.25 1.26 0.46
PBDT 180.05 207.26 200.31
Depreciation 17.06 15.97 15.16
Tax 38.94 47.88 46.81
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 2.51 1.55 1.38
Reported Profit After Tax 121.54 141.87 136.96
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 121.54 141.87 136.96
EPS (Unit Curr.) 9.91 11.57 11.18
EPS (Adj) (Unit Curr.) 9.91 11.57 11.18
Calculated EPS (Unit Curr.) 9.91 11.58 11.18
Calculated EPS (Adj) (Unit Curr.) 9.91 11.58 11.18
Calculated EPS (Ann.) (Unit Curr.) 39.64 46.31 44.71
Calculated EPS (Adj) (Ann.) (Unit Curr.) 39.64 46.31 44.71
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 24.53 24.51 24.51
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 30.12 32.10 31.28
PBDTM(%) 29.92 31.91 31.21
PATM(%) 20.19 21.84 21.34